The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Vorob’eva O.V.

Sechenov First Moscow State Medical University

Fateeva V.V.

Sechenov First Moscow State Medical University

Association of markers of endothelial dysfunction with depression in middle-aged patients with cerebral microangiopathy

Authors:

Vorob’eva O.V., Fateeva V.V.

More about the authors

Read: 2424 times


To cite this article:

Vorob’eva OV, Fateeva VV. Association of markers of endothelial dysfunction with depression in middle-aged patients with cerebral microangiopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(4):7‑11. (In Russ.)
https://doi.org/10.17116/jnevro20211210417

Recommended articles:
Factors supporting chro­nic inflammation in mental illness. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):7-15
Features of depressive diso­rders and suicidal beha­vior in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):7-13
Effe­cts of sema­glutide on mental health. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):28-36
Oxidative stress and depression in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):131-138
Chro­nic kidney disease and microcirculation diso­rders. Russian Journal of Preventive Medi­cine. 2025;(8):123-130
Psychodermatological aspe­cts of psoriasis, current condition of problem. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):403-411
«Metabolic health» and endo­thelial function in women with poly­cystic ovary syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):27-34

References:

  1. Liu Q, He H, Yang J, et al. Changes in the global burden of depression from 1990 to 2017: Findings from the Global Burden of Disease study. J Psychiatr Res. 2020;126:134–140.  https://doi.org/10.1016/j.jpsychires.2019.08.002
  2. Cardiovascular diseases (CVDs) [Internet]. World Health Organization; 2017 May 17. Accessed May 2, 2020. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
  3. Bogolepova AN. Depressive disorders in patients with chronic cerebral ischemia. Consillium Medicum. 2013;15(9):40–44. (In Russ.).
  4. Zakharov VV. Depression under cerebrovascular diseases. Effektivnaya farmakoterapiya. 2014;(31):4–11. (In Russ.).
  5. Vorob’eva OV. Clinical features of depression in general medical practice (according to the results of the Compass program). Consillium Medicum. 2004;6(2):154–158. (In Russ.).
  6. Vorob’eva OV. Valdoxan in the treatment of depression in neurological practice: the results of the Russian multicenter naturalistic study «Resonance». S.S. Korsakov Journal of Neurology and Psychiatry/Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2012;112(9):47–51. (In Russ.).
  7. Voznesenskaya TG. Depression in cerebrovascular diseases. Neurology, neuropsychiatry, psychosomatics. 2009;(2):9–13. (In Russ.).
  8. Voznesenskaya TG. Depression in cerebrovascular disease. Medical advice. 2012;(4):12–16. (In Russ.).
  9. Jani BD, Cavanagh J, Barry S, et al. Association between cardiovascular risk factors and concurrent depressive symptoms in cardiometabolic disease: a cross-sectional study. Lancet. 2014;384:S40.  https://doi.org/10.1016/S0140-6736(14)62166-8
  10. Godo S, Shimokawa H. Endothelial Functions. Arterioscler Thromb Vasc Biol. 2017;37(9):108–114.  https://doi.org/10.1161/ATVBAHA.117.309813
  11. Muxel S, Fasola F, Radmacher MC, et al. Endothelial functions: Translating theory into clinical application. Clin Hemorheol Microcirc. 2010;45(2–4):109–115.  https://doi.org/10.3233/CH-2010-1288
  12. Wardlaw JM, Smith EE, Biessels GJ. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–838.  https://doi.org/10.1016/S1474-4422(13)70124-8
  13. Kim YK, Jeon SW. Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders. Curr Neuropharmacol. 2018;16(5):574–582.  https://doi.org/10.2174/1570159X15666170913110426
  14. Oxenkrug G. Serotonin-kynurenine hypothesis of depression: historical overview and recent developments. Current Drug Targets. 2013;14(5):514–521.  https://doi.org/10.2174/1389450111314050002
  15. Myint AM. Kynurenines: from the perspective of major psychiatric disorders. FEBS J. 2012;279(8):1375–1385. https://doi.org/10.1111/j.1742-4658.2012.08551.x
  16. Steyers CM, Miller FJ. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci. 2014;15(7):11324–11349. https://doi.org/10.3390/ijms150711324
  17. Steven S, Frenis K, Oelze M, et al. Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease. Oxid Med Cell Longev. 2019;2019:7092151. https://doi.org/10.1155/2019/7092151
  18. Lopez-Vilchez I, Diaz-Ricart M, Navarro V, et al. Endothelial damage in major depression patients is modulated by SSRI treatment, as demonstrated by circulating biomarkers and an in vitro cell model. Translational psychiatry. 2016;6(9):e886. https://doi.org/10.1038/tp.2016.156
  19. Kheirabadi GR, Toghani F, Kousha M, et al. Is there any association of anxiety-depressive symptoms with vascular endothelial function or systemic inflammation? J Res Med Sci. 2018;18(11):979–983. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.